Vishwanath Halukurike, MD
Nephrology · Martinsville, VANPI 1437243656
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,913 of the $7,520 with a category attached, or 78.6%. It is spread thinly across 38 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,915 and has fallen 52.5% since, to $909 in 2025.
Across 298 payments — averaging $25.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$1K
- Mallinckrodt Hospital Products Inc.$895
- Vifor Pharma, Inc.$729
- Ardelyx, Inc.$663
- Otsuka America Pharmaceutical, Inc.$454
- Akebia Therapeutics Inc$392
- plus $3K from 32 others
What the payments were for
- Travel & lodging$1,08214%
- Food & beverage$5,91379%
- Education$4586%
- Other$671%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IGT D Peripheral$1,082
- XPHOZAH 30 MG$486
- JARDIANCE$122
- ACTHAR$119
- Veltassa$113
How this compares
$7,520 in reported general payments places this provider in the 85th percentile of 298 nephrology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 218 | $143,301 |
| JardianceEmpagliflozin | 102 | $67,999 |
| AuryxiaFerric Citrate | 20 | $49,297 |
| LokelmaSodium Zirconium Cyclosilicate | 36 | $23,879 |
| VeltassaPatiromer Calcium Sorbitex | 29 | $17,024 |
| Lanthanum Carbonate | 12 | $12,252 |
| Sevelamer Carbonate | 60 | $5,946 |
| Midodrine Hcl | 18 | $1,344 |
| Torsemide | 52 | $1,152 |
| Hydralazine Hcl | 141 | $1,066 |
| Potassium Chloride | 33 | $1,025 |
| Metoprolol Succinate | 92 | $821 |
| Calcitriol | 93 | $708 |
| Losartan Potassium | 135 | $597 |
| Amlodipine Besylate | 142 | $446 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Lokelma | $316 | $167,181254 claims |
| Boehringer IngelheimJardiance | $169 | $67,999102 claims |
| Akebia Therapeutics IncAuryxia | $392 | $49,29720 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 298 nephrology providers in Virginia.
Other nephrology in Martinsville
- Ramon MendezWoodbridge$791K
- Reza ZonoziFairfax$262K
- Sandeep MagoonNorfolk$204K
- Thomas McCuneNorfolk$202K
- Gaurav GuptaRichmond$168K
- Csaba KovesdySalem$152K
- Ramin TolouianNorfolk$115K
- Mahesh KrishnanMc Lean$115K
- Mitchell RosnerCharlottesville$105K
- Neeraja TandraReston$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.